Serum Institute of India
Logo of Serum Institute of India
|Founder||Cyrus S. Poonawalla|
|Cyrus S. Poonawalla (Chairman & MD)|
|Revenue||US$595 million (2015)|
|US$295 million (2015)|
Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. The company is managed by the Poonawalla group which fully owned by Cyrus Poonawalla. It is the world's largest vaccine producer by number of doses produced. The company is developing an intra-nasal swine flu vaccine. Co-developed with US-based Mass Biologics of the University of Massachusetts Medical School, it invented a fast acting anti-Rabies drug called Rabies Human Monoclonal Antibody (RMAb).
- "Cyrus Poonawalla on Forbes Lists". Forbes. Retrieved 24 March 2015.
- "'India developing indigenous swine flu vaccine'". The Times of India. Retrieved 1 February 2015.
- "Fast-acting anti-rabies drug set for India launch - Times of India". The Times of India. Retrieved 2016-06-12.
|This article about an Indian company is a stub. You can help Wikipedia by expanding it.|